NVCT
Nuvectis Pharma Inc

822
Loading...
Loading...
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Nuvectis Pharma Inc?
What is the 52-week high for Nuvectis Pharma Inc?
What is the 52-week low for Nuvectis Pharma Inc?
What is Nuvectis Pharma Inc stock price today?
What was Nuvectis Pharma Inc stock price yesterday?
What is the PE ratio of Nuvectis Pharma Inc?
What is the Price-to-Book ratio of Nuvectis Pharma Inc?
What is the 50-day moving average of Nuvectis Pharma Inc?
How many employess does Nuvectis Pharma Inc has?

Latest NVCT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.